Abstract
The objective of this study is to explore the diagnosis pattern of mid-trimester fetal chromosomal aneuploidy and its clinical applications. A large group of pregnant women (18–34 years) received dual serological screening. The elderly pregnant women, who were at high and critical risk and refused amniocentesis, underwent non-invasive detection of fetal DNA upon recommendation. Then, the pregnant women with positive non-invasive detection results received amniocentesis, amniotic cell culture, and karyotype analysis for confirmation. In total, 24,520 women and 629 elderly women (>35 years) received amniocentesis, amniotic cell culture, and karyotype analysis, and 1512 women received non-invasive detection of fetal DNA. A total of 275 women received invasive prenatal diagnosis. Seventeen cases of trisomy 21, 3 cases of trisomy 18, and 2 cases of sex chromosomal abnormality were diagnosed. The serological screening–gene detection–prenatal diagnosis for mid-trimester fetal chromosomal aneuploidy increased the detection rate, and decreased the frequency of invasive prenatal diagnosis.
Similar content being viewed by others
References
Levis, D. M., Harris, S., Whitehead, N., Moultrie, R., Duwe, K., & Rasmussen, S. A. (2012). Women’s knowledge, attitudes, and beliefs about Down syndrome: A qualitative research study. American Journal of Medical Genetics, 158A(6), 1355–1362.
Dressler, A., Perelli, V., Bozza, M., & Baragagna, S. (2011). The autistic phenotype in Down syndrome: Differences in adaptive behaviour versus Down syndrome alone and autistic disorder alone. Functional Neurology, 26, 151–158.
Dorota, K., Indumathi, V., Pranjul, S., Dimaki, M., Silahtaroglu, A., Tumer, Z., & Svendsen, E. W. (2012). Advanced microtechnologies for detection of chromosome abnormalities by fluorescent in situ hybridization. Biomedical Microdevices, 14, 453–460.
Li, X. (2011). Sex chromosomes and sex chromosome abnormalities. Clinics in Laboratory Medicine, 31, 463–479.
Down, J. L. (1995). Observations on an ethnic classification of idiots.1866. Mental Retardation, 33, 54–56.
Lejeune, J., Gautier, M., & Turpin, R. (1959). Study of somatic chromosomes from 9 mongoloid children. Comptes Rendus Hebdomadaires des Seances de l Academie des Sciences, 248, 1721–1722.
Kurt, B., & Nabiyev, V. V. (2011). Down syndrome recognition using local binary patterns and statistical evaluation of the system. Expert Systems with Application, 38(7), 8690–8695.
Khocht, A., Yaskell, T., Janal, M., Turner, B. F., Rams, T. E., Haffajee, A. D., & Socransky, S. S. (2012). Subgingival microbiota in adult down syndrome periodontitis. Journal of Periodontal Research, 47, 500–507.
Canzonetta, C., Hoischen, A., Giarin, E., Basso, G., Veltman, J. A., Nacheva, E., et al. (2012). Amplified segment in the ‘Down Syndrome critical region’ on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2. British Journal of Haematology, 157, 197–200.
Kainth, D. S., Chaudhry, S. A., Kainth, H. S., Suri, F. K., & Qureshi, A. I. (2013). Prevalence and characteristics of concurrent down syndrome in patients with moya moya disease. Neurosurgery, 72, 210–215.
Shiefa, M., Amarghi, J., Bhupendra, J., Moulali, S., & Kristine, T. (2013). First trimester maternal serum screening using biochemical markers PAPP-A and free beta-hCG for Down syndrome, Patau Syndrome and Edward Syndrome. Indian Journal of Clinical Biochemistry, 28, 3–12.
Krantz, D., Hallahan, T., Ravens, R., He, K., Cuckle, H., Sherwin, J., & Carmichael, J. (2011). First trimester Down syndrome screening with dried blood spots using a dual analyte free beta hCG and PAPP-A immunofluorometricassay. Prenatal Diagnosis, 31, 869–874.
Liu, F., Liang, H., Jiang, X., Zhang, Y., Xue, L., Yang, C., et al. (2011). Second trimester prenatal screening for Down’s syndrome in mainland Chinese subjects using double-marker analysis of alpha-fetoprotein and beta-human chorionic gonadotropin combined with measurement of nuchal fold thickness. Annals of the Academy of Medicine, Singapore, 40, 315–318.
Panova, G. A. S., Tatikolov, R. A., & Poltavtseva, Sukhikh G. T. (2011). Alpha-fetoprotein in human fetal vitreous body. Bulletin of Experimental Biology and Medicine, 150, 420–421.
Lo, Y. M., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet, 350, 485–487.
Chiu, R. W., Akolekar, R., Zheng, Y. W., Leung, T. Y., Sun, H., Chan, K. C., et al. (2011). Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:large scale validity study. BMJ, 342, c7401.
Lo, Y. M., & Chiu, R. W. (2012). Genomic analysis of fetal nucleic acids in maternal blood. Annual Review of Genomics and Human Genetics, 13, 285–306.
Verweij, E. J., de Boer, M. A., & Oepkes, D. (2012). Non-invasive prenatal diagnosis for Down syndrome: No paradigm shift, just better testing… and it is already here! Ultrasound in Obstetrics and Gynecology, 40, 484–485.
Patsalis, P. C., Tsaliki, E., Koumbaris, G., Karagrigoriou, A., Velissariou, V., & Papageorgiou, E. A. (2012). A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR. Expert Opinion on Biological Therapy, 12, S155–S161.
Dan, S., Wang, W., Ren, J., Li, Y., Hu, H., Xu, Z., et al. (2012). Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors. Prenatal Diagnosis, 32(13), 1225–1232.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yuan Fang and Guangming Wang are co-first authors.
Rights and permissions
About this article
Cite this article
Fang, Y., Wang, G., Wang, C. et al. The Diagnosis Pattern of Mid-Trimester Fetal Chromosomal Aneuploidy in Xuzhou and the Clinical Applications. Cell Biochem Biophys 73, 267–270 (2015). https://doi.org/10.1007/s12013-015-0594-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-015-0594-8